ACGT® - About ACGT - Scientific Advisory Council

Scientific Advisory Council

ACGT’S Scientific Advisory Council is composed of 16 of the nation’s preeminent physicians and researchers in cell and gene therapy. Council members, who serve without remuneration, establish the scientific criteria for review of all grants and develop strict accountability guidelines requiring periodic progress reports. The Council submits recommendations for funding to the Board of Directors for final selection of award recipients.

Chairman

Savio L.C. Woo, Ph.D. (bio)
Chairman and Professor, Department of Gene and Cell Medicine
Mt. Sinai School of Medicine
New York, NY

Council Members

Stuart A. Aaronson, M.D. (bio)
Chairman, Department of Oncological Sciences;
Jack and Jane B. Aron Professor of Neoplastic Diseases
Mount Sinai School of Medicine
New York, NY

Xandra O. Breakefield, Ph.D. (bio)
Professor, Department of Neurology,
Harvard Medical School;
Geneticist , Molecular Neurogenetics Unit
Massachusetts General Hospital
Boston, MA

Lieping Chen M.D., Ph.D. (bio)
Professor of Dermatology, Oncology, Immunology and Cellular & Molecular Medicine;
Director of Research, Department of Dermatology
Johns Hopkins University School of Medicine
Baltimore, MD

Stephen L. Eck, M.D., Ph.D. (bio)
Vice President
Translational Medicine & Pharmacogenomics
Eli Lilly and Company
Indianapolis, IN

Joseph C. Glorioso III, Ph.D. (bio)
Chairman and Professor of the Department of Molecular Genetics and Biochemistry
University of Pittsburgh School of Medicine
Pittsburgh, PA

Carl H. June, M.D (bio)
Director, Translational Research
Professor, Department of Pathology and Laboratory Medicine
Abramson Family Cancer Research Institute
University of Pennsylvania
Philadelphia, PA

Michael T. Lotze, M.D. (bio)
Professor of Surgery & Bioengineering
Vice Chair Research, Department of Surgery
Director, Strategic Partnerships,
University of Pittsburgh Cancer Institute
Pittsburgh, PA

Robert L. Martuza, M.D., F.A.C.S. (bio)
Chief of Neurosurgery at Massachusetts General Hospital
and William and Elizabeth Sweet Professor of Neuroscience at Harvard Medical School
Boston, MA

A. Dusty Miller, Ph.D. (bio)
Member of the Divisions of Human Biology and Basic Sciences
Fred Hutchinson Cancer Research Center; Affiliate Professor, Department of Patholgy
University of Washington
Seattle, WA

John Nemunaitis, M.D. (bio)
Executive Medical Director
Mary Crowley Medical Research Centers
Dallas, TX

Drew M. Pardoll, M.D., Ph.D. (bio)
Seraph Professor in Oncology
Co-Director, Cancer Immunology and Hematopoiesis Program;
Professor of Medicine, Oncology, Pathology and Molecular Biology & Genetics;
Sidney Kimmel Cancer Center
Johns Hopkins University School of Medicine
Baltimore, MD

Jack A. Roth, M.D., F.A.C.S. (bio)
Professor and Bud Johnson Clinical Distinguished Chair;
Chief, Section of Thoracic Molecular Oncology;
Professor of Molecular & Cellular Oncology;
Director, W.M. Keck Center for Innovative Cancer Therapies;
The University of Texas MD Anderson Cancer Center
Houston, TX

Stephen J. Russell, M.D., Ph.D. (bio)
Director, Molecular Medicine Program;
Consultant, Department of Hematology;
Professor of Medicine
Mayo Clinic,
Rochester, MN

Michel Sadelain, M.D., Ph.D. (bio)
Head, Laboratory of Gene Therapy and Gene Expression;
Member, Department of Medicine and Molecular Pharmacology Program;
Director, Center for Cell Engineering
Memorial Sloan-Kettering Cancer Center
New York, NY

Thomas J. Wickham, Ph.D. (bio)
Senior Director, Research
Merrimack Pharmaceuticals
Cambridge, MA

George D. Yancopoulos, M.D., Ph.D. (bio)
President, Regeneron Laboratories & Chief Scientific Officer
Regeneron Pharmaceuticals, Inc.
Tarrytown, NY

Home | About ACGT | Contact ACGT | Site Contents | Privacy Policy